Corcept Therapeutics | CORT - Trade Creditors

Stock Price
40.80
Daily Change
-0.05 -0.12%
Monthly
20.04%
Yearly
-42.12%
Q2 Forecast
41.21

Corcept Therapeutics reported $40.44M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 10.9M 10.84M Dec/2025
Alaunos Therapeutics USD 843K 34K Sep/2025
ANI Pharmaceuticals USD 62.58M 7.21M Dec/2025
Ardelyx USD 19.24M 845K Dec/2025
Assertio Holdings USD 14.66M 3.81M Sep/2025
Aurora Cannabis CAD 68.03M 18.68M Dec/2025
BioMarin Pharmaceutical USD 759.03M 39.41M Dec/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Canopy Growth CAD 19.96M 1.83M Dec/2025
Corcept Therapeutics USD 40.44M 6M Dec/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Esperion Therapeutics USD 65.07M 12.44M Dec/2025
J&J USD 11.99B 2.37B Dec/2025
Knight Therapeutics CAD 125.76M 7.63M Dec/2025
Lexicon Pharmaceuticals USD 3.08M 714K Dec/2025
Merck USD 4.15B 102M Sep/2025
Nektar Therapeutics USD 10.77M 4.79M Dec/2025
Novartis USD 4.46B 99M Dec/2025
Novartis USD 4.46B 99M Dec/2025
Omeros USD 8.84M 4.42M Jun/2025
Pacira USD 15.15M 2.54M Dec/2025
Pfizer USD 5.02B 142M Sep/2025
Supernus Pharmaceuticals USD 107.8M 813K Dec/2025
TG Therapeutics USD 61.64M 72.38M Sep/2025